Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study

被引：0
作者：
Markovic, S. [1 ]
Kralj, D. [1 ]
Ivanovski, T. Knezevic [1 ]
Kalaba, A. [1 ]
Odanovic, O. [1 ]
Homsek, A. [2 ]
Svorcan, P. [1 ]
Vucicevic, K. [2 ]
机构：
[1] Clin Ctr Univ Hosp Zvezdara, Gastroenterol & Hepatol Dept, Belgrade, Serbia
[2] Univ Belgrade, Fac Pharm, Dept Pharmacokinet & Clin Pharm, Belgrade, Serbia
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1093/ecco-jcc/jjae190.0797
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0623
引用
收藏
页码：I1231 / I1231
页数：1
相关论文
共 3 条
  • [1] Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases
    Dreesen, Erwin
    Verstockt, Bram
    Bian, Sumin
    de Bruyn, Magali
    Compernolle, Griet
    Tops, Sophie
    Noman, Maja
    Van Assche, Gert
    Ferrante, Marc
    Gils, Ann
    Vermeire, Severine
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (12) : 1937 - +
  • [2] Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Feagan, Brian G.
    Rutgeerts, Paul
    Sands, Bruce E.
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Sandborn, William J.
    Van Assche, Gert
    Axler, Jeffrey
    Kim, Hyo-Jong
    Danese, Silvio
    Fox, Irving
    Milch, Catherine
    Sankoh, Serap
    Wyant, Tim
    Xu, Jing
    Parikh, Asit
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) : 699 - 710
  • [3] Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
    Sandborn, William J.
    Feagan, Brian G.
    Rutgeerts, Paul
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Lukas, Milan
    Fedorak, Richard N.
    Lee, Scott
    Bressler, Brian
    Fox, Irving
    Rosario, Maria
    Sankoh, Serap
    Xu, Jing
    Stephens, Kristin
    Milch, Catherine
    Parikh, Asit
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) : 711 - 721
1